ADC Therapeutics SA Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| REDMILE GROUP, LLC | 11/14/2024 | 15.67 M | $49.36 M | 2.62% | 14.95% |
| PROSIGHT MANAGEMENT, LP | 11/14/2024 | 9.64 M | $30.35 M | 0.69% | 9.19% |
| ORBIMED ADVISORS LLC | 11/14/2024 | 4.53 M | $14.28 M | 5.03% | 4.33% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 4.40 M | $13.86 M | 100.00% | 4.20% |
| MORGAN STANLEY | 11/14/2024 | 3.04 M | $9.58 M | 2.55% | 2.90% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.50 M | $7.87 M | 105.35% | 2.38% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.80 M | $5.65 M | 1.49% | 1.71% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.69 M | $5.32 M | 10.75% | 1.61% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 11/08/2024 | 1.44 M | $4.55 M | 11.45% | 1.38% |
| SIREN, L.L.C. | 11/13/2024 | 1.16 M | $3.66 B | 100.00% | 1.11% |
| STATE STREET CORP | 11/14/2024 | 1.11 M | $3.48 M | 11.57% | 1.06% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 953,171 | $3.00 M | 15.58% | 0.91% |
| VANTAGE CONSULTING GROUP INC | 11/14/2024 | 850,737 | $2.68 B | 0.00% | 0.81% |
| BLUE OWL CAPITAL HOLDINGS LP | 11/14/2024 | 733,568 | $2.31 M | 0.00% | 0.70% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 712,401 | $2.24 M | -12.74% | 0.68% |
| VANGUARD GROUP INC | 11/13/2024 | 539,359 | $1.70 M | 33.43% | 0.51% |
| GCM GROSVENOR HOLDINGS, LLC | 11/14/2024 | 410,888 | $1.29 M | 0.00% | 0.39% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 284,243 | $895,365 | 7.79% | 0.27% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 245,253 | $772,547 | -25.40% | 0.23% |
| SPHERA FUNDS MANAGEMENT LTD. | 11/14/2024 | 205,036 | $645,863 | -70.09% | 0.20% |
| DAFNA CAPITAL MANAGEMENT LLC | 11/14/2024 | 204,081 | $642,855 | 0.00% | 0.19% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 194,258 | $611,913 | 10.71% | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 168,557 | $530,955 | 100.00% | 0.16% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 162,243 | $511,065 | -20.94% | 0.15% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 129,058 | $406,533 | -45.61% | 0.12% |
| BARCLAYS PLC | 11/19/2024 | 127,739 | $402,000 | 277.38% | 0.12% |
| XTX TOPCO LTD | 11/14/2024 | 115,073 | $362,480 | 102.37% | 0.11% |
| SANIBEL CAPTIVA TRUST COMPANY, INC. | 10/08/2024 | 113,000 | $355,950 | 0.00% | 0.11% |
| BRYN MAWR TRUST CO | 11/25/2024 | 100,000 | $315,000 | 100.00% | 0.10% |
| RHUMBLINE ADVISERS | 11/12/2024 | 95,189 | $299,839 | 10.71% | 0.09% |
| JPMORGAN CHASE & CO | 12/26/2024 | 78,813 | $248,261 | 164.15% | 0.08% |
| SQUAREPOINT OPS LLC | 11/14/2024 | 75,392 | $237,485 | 100.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 73,700 | $232,155 | -57.23% | 0.07% |
| MAGNETAR FINANCIAL LLC | 11/13/2024 | 55,762 | $175,650 | 0.00% | 0.05% |
| JANE STREET GROUP, LLC | 11/15/2024 | 53,126 | $167,347 | 272.37% | 0.05% |
| FMR LLC | 11/13/2024 | 53,042 | $167,084 | 100.00% | 0.05% |
| COREBRIDGE FINANCIAL, INC. | 11/13/2024 | 43,481 | $136,965 | 15.44% | 0.04% |
| METLIFE INVESTMENT MANAGEMENT, LLC | 11/13/2024 | 43,089 | $135,730 | 129.08% | 0.04% |
| COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 40,413 | $127,000 | 23.97% | 0.04% |
| UBS GROUP AG | 11/14/2024 | 39,775 | $125,292 | 87.68% | 0.04% |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 11/14/2024 | 38,274 | $120,563 | 100.00% | 0.04% |
| SECTORAL ASSET MANAGEMENT INC | 11/14/2024 | 36,214 | $114.07 M | -84.12% | 0.03% |
| DLK INVESTMENT MANAGEMENT, LLC | 10/09/2024 | 33,155 | $104,438 | 0.00% | 0.03% |
| INVESCO LTD. | 11/12/2024 | 32,669 | $102,907 | -0.88% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 31,500 | $99,225 | 10.53% | 0.03% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 29,998 | $94,494 | 16.71% | 0.03% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 29,276 | $92,219 | -18.85% | 0.03% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 28,831 | $91,000 | 100.00% | 0.03% |
| SG AMERICAS SECURITIES, LLC | 10/03/2024 | 26,657 | $84,000 | 100.00% | 0.03% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 25,831 | $81,368 | -4.11% | 0.02% |
ADC Therapeutics SAinstitutional Ownership - FAQ's
During the previous two years, 93 institutional investors and hedge funds held shares of ADC Therapeutics SA. The most heavily invested institutionals were:
Redmile Group, LLC: 15.67 M
Prosight Management, LP: 9.64 M
ORBIMED ADVISORS LLC: 4.53 M
BlackRock Funding, Inc. /DE: 4.4 M
MORGAN STANLEY: 3.04 M
BANK OF AMERICA CORP /DE/: 2.5 M
52.36% of ADC Therapeutics SA stock is owned by institutional investors.
Institutional investors have bought a total of 60.77 M shares in the last 24 months. This purchase volume represents approximately $128.82 M in transactions.